University of Texas Health Science Center at San Antonio-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2022

  1. MPN-141 Retrospective Comparison of Patient Outcomes on Pacritinib Versus Ruxolitinib in Patients With Myelofibrosis and Thrombocytopenia

    Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, pp. S326-S327